Abstract

Hepatitis C virus (HCV) infects B lymphocytes and induces mixed cryoglobulinemia and B cell non-Hodgkin's lymphoma. The molecular mechanism for the pathogenesis of HCV infection-mediated B cell disorders remains obscure. To identify the possible role for HCV nonstructural 5A (NS5A) protein in B cells, we generated the stable B cell lines expressing Myc-His tagged NS5A. Immunoprecipitation study in the presence or absence of pervanadate (PV) implied that NS5A was tyrosine phosphorylated by pervanadate (PV) treatment of the cells. Therefore we examined pull-down assay by using glutathione S-transferase (GST)-fusion proteins of various Src homology 2 (SH2) domains, which associates with phosphotyrosine within a specific amino acid sequence. The results showed that NS5A specifically bound to SH2 domain of Fyn from PV-treated B cells in addition to Src homology 3 (SH3) domain. Substitution of Arg176 to Lys in the SH2 domain of Fyn abrogated this interaction. Deletion mutational analysis demonstrated that N-terminal region of NS5A was not required for the interaction with the SH2 domain of Fyn. Tyr334 was identified as a tyrosine phosphorylation site in NS5A. Far-western analysis revealed that SH2 domain of Fyn directly bound to NS5A. Fyn and NS5A were colocalized in the lipid raft. These results suggest that NS5A directly binds to the SH2 domain of Fyn in a tyrosine phosphorylation-dependent manner. Lastly, we showed that the expression of NS5A in B cells increased phosphorylation of activation loop tyrosine in the kinase domain of Fyn. NS5A containing ligand for both SH2 and SH3 domains enhances an aberrant autophosphorylation and kinase activity of Fyn in B cells.

Highlights

  • Hepatitis C virus (HCV) is a small enveloped positive-sense RNA virus classified within the family Flaviviridae [1,2]

  • We have demonstrated the possible tyrosine phosphorylation of nonstructural 5A (NS5A) in B cells and the interaction of NS5A with the Src homology 2 (SH2) domain of Fyn, in addition to Src homology 3 (SH3) domain

  • Previous reports demonstrated that cells harboring HCV replicon possesses the increased kinase activity of Fyn, which supports our conclusion of this study [9]

Read more

Summary

Introduction

HCV is a small enveloped positive-sense RNA virus classified within the family Flaviviridae [1,2]. In addition to liver cells, HCV infects B cells, leading to mixed cryoglobulinemia and B cell nonHodgkin’s lymphoma [3,4,5]. HCV infection in B cells enhances the expression of lymphomagenesis-related genes, such as activation-induced cytidine deaminase (AID) [6,7]. The molecular mechanisms of HCV infection-mediated B cell disorders remain elusive. Non-receptor type of protein-tyrosine kinase Fyn is a member of the Src family kinases, and has regulatory roles in immune receptor signaling. Fyn has been recognized as an important mediator of mitogenic signaling and regulator of cell cycle entry, growth and proliferation. As for pathological aspects, Fyn is overexpressed in various cancers, and overexpression of Fyn in cultured cells resulted in cancer-like phenotypes [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call